课题基金 / 基金详情

Cardiac Synchronization Technology for PEA Patients

Cardiac Synchronization Technology for PEA Patients
适用于 PEA 患者的心脏同步技术
批准号:
6935528
负责人:
JON VONOHLSEN
金额:
$9.1万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2006-06-15

项目摘要

项目成果

JON VONOHLSEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pulseless electrical activity (PEA) also referred to as electromechanical dissociation (EMD), has been described as "the presence of organized electrical activity on the electrocardiogram but without palpable pulses." It is the common end-point for a number of processes that interfere with cardiopulmonary function, in particular major cardiac insults and respiratory failure with hypoxia. The vast majority of patients suffering PEA in the out-of-hospital setting will not survive. Therefore, an effective treatment for PEA could be extraordinarily important. Previous research has demonstrated that a large fraction of patients in PEA actually have residual cardiac mechanical activity. The research team has developed a hypothesis that outcomes may improve if cardiac compressions are synchronized with residual myocardial mechanical activity. In other words, we hypothesize that outcomes will improve if compressions are timed to assist ejection -- squeezing the chest during intrinsic contractions -- and relaxing so as to allow adequate ventricular filling during intrinsic diastole. In response to NIH Program Announcement (PA) 04-059 - Technologies for Monitoring and Performing Resuscitation, Rose Biomedical Development Corporation proposes to develop and pilot test Cardiac Synchronization Technology (CST), a non-invasive approach to improving outcomes by synchronizing chest compression with residual cardiac mechanical activity in patients with pseudo-EMD PEA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiac Synchronization Technology for PEA Patients
Cardiac Synchronization Technology: Resuscitation Therapy - Pulseless Cardiac Arr
Cardiac Synchronization Technology: Resuscitation Therapy - Pulseless Cardiac Arr
海外基金